COL7A1 and recessive dystrophic epidermolysis bullosa: In addition, following systemic intravenous grafting, ABCB5+ MSCs reduced RDEB symptoms and significantly prolonged the lifespan in a Col7a1–/– mouse model of RDEB [18].